Peter G. Tipping
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter G. Tipping has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Stephen R. Holdsworth
Centre for Inflammatory Diseases, Department of Medicine, Monash Institute for Medical Research, Monash University, Clayton, Victoria, Australia
9 shared publicationsA. Richard Kitching
From the Center for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Center, Clayton, Victoria, Australia
3 shared publications- Shuo Li
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland; Department of Microbiology, Monash University, Melbourne, Victoria, Australia
3 shared publications - Arthur Richard Kitching
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria 3168, Australia
2 shared publications Jennifer R. Timoshanko
Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, 246 Clayton Road, Clayton, Victoria 3168, Australia
2 shared publicationsMalcolm A. Cunningham
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, 3168 Victoria, Australia
2 shared publications
Latest Publications
- 1 November 2010
- Published by Oxford University Press (OUP)
- p. 105-128
Pathways of cellular adaptive immunity in autoimmune crescentic glomerulonephritis and lupus nephritis
- 1 November 2010
- Published by Oxford University Press (OUP)
- p. 105-128
Pathways of cellular adaptive immunity in autoimmune crescentic glomerulonephritis and lupus nephritis
- 16 June 2008
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 23 (10) , 3065-3066
Crescentic nephritis--is it in your genes?
- 16 June 2008
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 23 (10) , 3065-3066
Crescentic nephritis--is it in your genes?
- 1 May 2007
- Published by Elsevier in Seminars in Nephrology
- Vol. 27 (3) , 275-285
Cytokines in Glomerulonephritis
- 1 May 2007
- Published by Elsevier in Seminars in Nephrology
- Vol. 27 (3) , 275-285
Cytokines in Glomerulonephritis
- Open Access
- 1 July 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (7) , 1769-1771
Toll-Like Receptors
- 1 July 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (7) , 1769-1771
Open AccessToll-Like Receptors
- Open Access
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (5) , 1253-1263
T Cells in Crescentic Glomerulonephritis
Crescent formation in glomerulonephritis (GN) is a manifestation of severe glomerular injury that usually results in a poor clinical outcome. In humans, crescentic GN is frequently associated with evidence of either systemic or organ-specific autoimmunity. T cells play a major role in initiation of adaptive immune responses that lead to crescentic injury. In experimental models of crescentic GN, Th1 predominant immune responses have been shown to promote crescent formation. Perturbation of regulatory T cell function may contribute to development of autoimmune crescentic GN. The presence of T cells and macrophages in crescentic glomeruli, frequently in the absence of humoral mediators of immunity, suggest a dominant effector role for T cells in crescentic GN. The association of cellular immune mediators with local fibrin deposition implicates cell-mediated “delayed-type hypersensitivity–like” mechanisms in crescent formation. Intrinsic renal cells also contribute to T cell–driven effector mechanisms in crescentic GN, via expression of MHC II and co-stimulatory molecules and by production of chemokines and cytokines that amplify leukocyte recruitment and injury.
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 17 (5) , 1253-1263
Open AccessT Cells in Crescentic Glomerulonephritis
Crescent formation in glomerulonephritis (GN) is a manifestation of severe glomerular injury that usually results in a poor clinical outcome. In humans, crescentic GN is frequently associated with evidence of either systemic or organ-specific autoimmunity. T cells play a major role in initiation of adaptive immune responses that lead to crescentic injury. In experimental models of crescentic GN, Th1 predominant immune responses have been shown to promote crescent formation. Perturbation of regulatory T cell function may contribute to development of autoimmune crescentic GN. The presence of T cells and macrophages in crescentic glomeruli, frequently in the absence of humoral mediators of immunity, suggest a dominant effector role for T cells in crescentic GN. The association of cellular immune mediators with local fibrin deposition implicates cell-mediated “delayed-type hypersensitivity–like” mechanisms in crescent formation. Intrinsic renal cells also contribute to T cell–driven effector mechanisms in crescentic GN, via expression of MHC II and co-stimulatory molecules and by production of chemokines and cytokines that amplify leukocyte recruitment and injury.
- 9 September 2005
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 101 (4) , e173-e177
Contributions of Intrinsic Renal Cells to Crescentic Glomerulonephritis
The pro-inflammatory contributions of leukocytes, particularly macrophages and T cells, to the immunopathogenesis of proliferative forms of glomerulonephritis (GN) have been clearly established by various techniques, including in vivo depletion studies in experimental models. The evidence for an active pro-inflammatory role for intrinsic renal cells in GN has relied on studies demonstrating their production of pro-inflammatory mediators in vitro and during the development of GN. Until recently,the specific in vivo contributions of mediators from intrinsic renal cells to inflammatory injury in GN have proven difficult to define. Utilising ‘chimeric’ mice as a tool, several studies have explored the involvement of intrinsic renal cells via their production of cytokines and other key pro-inflammatory molecules. These studies provide evidence of important functional contributions of intrinsic renal cells to inflammatory injury in GN via their expression of cytokines, cytokine receptors, MHC-II and co-stimulatory molecules. They suggest a sequence of interactions between cytokines from leukocytes and intrinsic renal cells and important contributions of glomerular epithelial cell proliferation to crescent formation.
- 9 September 2005
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 101 (4) , e173-e177
Contributions of Intrinsic Renal Cells to Crescentic Glomerulonephritis
The pro-inflammatory contributions of leukocytes, particularly macrophages and T cells, to the immunopathogenesis of proliferative forms of glomerulonephritis (GN) have been clearly established by various techniques, including in vivo depletion studies in experimental models. The evidence for an active pro-inflammatory role for intrinsic renal cells in GN has relied on studies demonstrating their production of pro-inflammatory mediators in vitro and during the development of GN. Until recently,the specific in vivo contributions of mediators from intrinsic renal cells to inflammatory injury in GN have proven difficult to define. Utilising ‘chimeric’ mice as a tool, several studies have explored the involvement of intrinsic renal cells via their production of cytokines and other key pro-inflammatory molecules. These studies provide evidence of important functional contributions of intrinsic renal cells to inflammatory injury in GN via their expression of cytokines, cytokine receptors, MHC-II and co-stimulatory molecules. They suggest a sequence of interactions between cytokines from leukocytes and intrinsic renal cells and important contributions of glomerular epithelial cell proliferation to crescent formation.
- 28 July 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 142 (2) , 207-215
Glomerulonephritis, Th1 and Th2: what's new?
Summary: Glomerulonephritis (GN), the major worldwide cause of chronic renal disease and renal failure, shows a wide spectrum of histological patterns, severity of injury and clinical outcomes that may be related to the nature of the nephritogenic immune response. In the majority of cases, there is evidence of a central role for cognate immunity in the initiation of human GN and contributions of both humoral and cellular effector mechanisms have been demonstrated in both humans and in animal models. T helper cell subsets are known to activate different immune effector mechanisms which influence disease outcomes in infectious and autoimmune diseases and evidence is now accumulating that Th1 and Th2 subsets direct diverging effector pathways that lead to different patterns and severity of glomerular injury in GN. Th1-predominant responses appear to be associated strongly with proliferative and crescentic forms of GN that result in severe renal injury, while Th2 responses are associated with membranous patterns of injury. The challenge remains to understand fully the relevance of T helper cell subset responses to the spectrum of human GN and to apply this new knowledge to the development of more potent and selective therapeutic strategies.
- 28 July 2005
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 142 (2) , 207-215
Glomerulonephritis, Th1 and Th2: what's new?
Summary: Glomerulonephritis (GN), the major worldwide cause of chronic renal disease and renal failure, shows a wide spectrum of histological patterns, severity of injury and clinical outcomes that may be related to the nature of the nephritogenic immune response. In the majority of cases, there is evidence of a central role for cognate immunity in the initiation of human GN and contributions of both humoral and cellular effector mechanisms have been demonstrated in both humans and in animal models. T helper cell subsets are known to activate different immune effector mechanisms which influence disease outcomes in infectious and autoimmune diseases and evidence is now accumulating that Th1 and Th2 subsets direct diverging effector pathways that lead to different patterns and severity of glomerular injury in GN. Th1-predominant responses appear to be associated strongly with proliferative and crescentic forms of GN that result in severe renal injury, while Th2 responses are associated with membranous patterns of injury. The challenge remains to understand fully the relevance of T helper cell subset responses to the spectrum of human GN and to apply this new knowledge to the development of more potent and selective therapeutic strategies.
- 1 July 2003
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (7) , 1785-1793
Intrinsic Renal Cells Are the Major Source of Tumor Necrosis Factor Contributing to Renal Injury in Murine Crescentic Glomerulonephritis
Macrophages are prominent participants in crescentic glomerulonephritis (GN) and have been suggested to be the major source of TNF in this cell-mediated form of glomerular inflammation. Intrinsic renal cells also have the capacity to produce TNF. For dissecting the contribution of local versus bone marrow (BM)-derived TNF in inflammatory renal injury, TNF chimeric mice were created by transplanting normal wild-type (WT) BM into irradiated TNF-deficient recipients (WT→TNF−/− chimeras) and vice versa (TNF−/−→WT chimeras). A model of crescentic GN induced by an intravenous injection of sheep anti-murine glomerular basement membrane antibody was studied in WT mice, mice with complete TNF deficiency (TNF−/−), and chimeric mice. Crescentic GN was attenuated in TNF−/− mice with fewer crescents (crescents, 13.7 ± 1.7% of glomeruli) and reduced functional indices of renal injury (serum creatinine, 15.2 ± 0.8 μmol/L). Similar protection (crescents, 14.3 ± 1.9% of glomeruli; serum creatinine, 18.9 ± 1.1 μmol/L) was observed in chimeric mice with intact BM but absent renal-derived TNF (WT→TNF−/− chimeras), suggesting a minor contribution of infiltrating leukocytes to TNF-mediated renal injury. Chimeric mice with TNF-deficient leukocytes but intact intrinsic renal cell-derived TNF (crescents, 20.5 ± 2.0% of glomeruli; serum creatinine, 21.6 ± 1.4 μmol/L) developed similar crescentic GN to WT mice (crescents, 22.3 ± 1.4% of glomeruli; serum creatinine, 24.8 ± 1.9 μmol/L). Cutaneous delayed-type hypersensitivity after subdermal challenge with the nephritogenic antigen was attenuated in the absence of BM cell-derived TNF but unaffected in WT→TNF−/− chimeric mice. These studies suggest that intrinsic renal cells are the major cellular source of TNF contributing to inflammatory injury in crescentic GN. E-mail: peter.tipping@med.monash.edu.au
- 1 July 2003
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (7) , 1785-1793
Intrinsic Renal Cells Are the Major Source of Tumor Necrosis Factor Contributing to Renal Injury in Murine Crescentic Glomerulonephritis
Macrophages are prominent participants in crescentic glomerulonephritis (GN) and have been suggested to be the major source of TNF in this cell-mediated form of glomerular inflammation. Intrinsic renal cells also have the capacity to produce TNF. For dissecting the contribution of local versus bone marrow (BM)-derived TNF in inflammatory renal injury, TNF chimeric mice were created by transplanting normal wild-type (WT) BM into irradiated TNF-deficient recipients (WT→TNF−/− chimeras) and vice versa (TNF−/−→WT chimeras). A model of crescentic GN induced by an intravenous injection of sheep anti-murine glomerular basement membrane antibody was studied in WT mice, mice with complete TNF deficiency (TNF−/−), and chimeric mice. Crescentic GN was attenuated in TNF−/− mice with fewer crescents (crescents, 13.7 ± 1.7% of glomeruli) and reduced functional indices of renal injury (serum creatinine, 15.2 ± 0.8 μmol/L). Similar protection (crescents, 14.3 ± 1.9% of glomeruli; serum creatinine, 18.9 ± 1.1 μmol/L) was observed in chimeric mice with intact BM but absent renal-derived TNF (WT→TNF−/− chimeras), suggesting a minor contribution of infiltrating leukocytes to TNF-mediated renal injury. Chimeric mice with TNF-deficient leukocytes but intact intrinsic renal cell-derived TNF (crescents, 20.5 ± 2.0% of glomeruli; serum creatinine, 21.6 ± 1.4 μmol/L) developed similar crescentic GN to WT mice (crescents, 22.3 ± 1.4% of glomeruli; serum creatinine, 24.8 ± 1.9 μmol/L). Cutaneous delayed-type hypersensitivity after subdermal challenge with the nephritogenic antigen was attenuated in the absence of BM cell-derived TNF but unaffected in WT→TNF−/− chimeric mice. These studies suggest that intrinsic renal cells are the major cellular source of TNF contributing to inflammatory injury in crescentic GN. E-mail: peter.tipping@med.monash.edu.au
- 1 March 2001
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 12 (3) , 464-471
Interleukin-12 from Intrinsic Cells Is an Effector of Renal Injury in Crescentic Glomerulonephritis
: Interleukin-12 (IL-12) directs the cognate nephritogenic T helper type 1 responses that initiate renal injury in murine crescentic glomerulonephritis (GN). The recent demonstration of IL-12 production by intrinsic renal cells, including mesangial and proximal tubular cells, raises the possibility that IL-12 from nonimmune cells may contribute to inflammatory renal injury. To address this possibility, the development of sheep anti-mouse glomerular basement membrane globulin—induced crescentic GN was studied in C57BL/6 wild-type (WT), IL-12—deficient (IL-12 -/-), and IL-12 “chimeric” mice. IL-12 chimeric mice were produced by transplantation of WT bone marrow into IL-12 -/- mice to restore IL-12 production by immune cells, while leaving them deficient in renal IL-12 production. WT and “sham” chimeric mice (normal bone marrow transplanted into WT mice) developed crescentic GN with glomerular T-cell and macrophage recruitment and impaired renal function (elevated proteinuria and serum creatinine) 10 d after initiation of GN. IL-12 -/- mice showed significant protection from GN. Chimeric IL-12 mice showed significant attenuation of crescent formation, glomerular T-cell and macrophage accumulation, and renal impairment, compared with WT and sham chimeric mice, but were not protected to the same extent as IL-12 -/- mice. IL-12 chimeric mice showed no attenuation of their systemic cognate immune response to the nephritogenic antigen (sheep globulin), indicated by antigen-specific circulating antibody and cutaneous delayed-type hypersensitivity. These studies indicate that IL-12 produced by non—bone marrow derived intrinsic renal cells contributes to immune renal injury. They provide the first in vivo demonstration of a proinflammatory role for an intrinsic renal cell—derived cytokine in renal inflammation.
- 1 March 2001
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 12 (3) , 464-471
Interleukin-12 from Intrinsic Cells Is an Effector of Renal Injury in Crescentic Glomerulonephritis
: Interleukin-12 (IL-12) directs the cognate nephritogenic T helper type 1 responses that initiate renal injury in murine crescentic glomerulonephritis (GN). The recent demonstration of IL-12 production by intrinsic renal cells, including mesangial and proximal tubular cells, raises the possibility that IL-12 from nonimmune cells may contribute to inflammatory renal injury. To address this possibility, the development of sheep anti-mouse glomerular basement membrane globulin—induced crescentic GN was studied in C57BL/6 wild-type (WT), IL-12—deficient (IL-12 -/-), and IL-12 “chimeric” mice. IL-12 chimeric mice were produced by transplantation of WT bone marrow into IL-12 -/- mice to restore IL-12 production by immune cells, while leaving them deficient in renal IL-12 production. WT and “sham” chimeric mice (normal bone marrow transplanted into WT mice) developed crescentic GN with glomerular T-cell and macrophage recruitment and impaired renal function (elevated proteinuria and serum creatinine) 10 d after initiation of GN. IL-12 -/- mice showed significant protection from GN. Chimeric IL-12 mice showed significant attenuation of crescent formation, glomerular T-cell and macrophage accumulation, and renal impairment, compared with WT and sham chimeric mice, but were not protected to the same extent as IL-12 -/- mice. IL-12 chimeric mice showed no attenuation of their systemic cognate immune response to the nephritogenic antigen (sheep globulin), indicated by antigen-specific circulating antibody and cutaneous delayed-type hypersensitivity. These studies indicate that IL-12 produced by non—bone marrow derived intrinsic renal cells contributes to immune renal injury. They provide the first in vivo demonstration of a proinflammatory role for an intrinsic renal cell—derived cytokine in renal inflammation.
- 24 December 2000
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 122 (3) , 453-458
MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice
SUMMARY: MHC II and CD4+ T cells are required for anti-glomerular basement membrane (GBM) globulin-initiated crescentic glomerulonephritis (GN) in mice, but the role of MHC I and CD8+ T cells is unclear. The cytolytic function of CD8+ T cells requires recognition of peptide antigens presented on MHC I. CD8+ T cells can also perform helper functions via cytokine production. The contribution of MHC I to crescentic GN was investigated using TAP-1 gene knock out (TAP-1−/−) mice, which have deficient MHC I antigen presentation. Heterozygous TAP-1 mice have normal MHC I expression and developed GN with crescents in 42 ± 4% of glomeruli (normal 0%), proteinuria (9·1 ± 1·6 mg/20 h, normal 1·5 ± 0·3 mg/20 h) and impaired renal function (creatinine clearance 110 ± 8 μl/min, normal 193 ± 10 μl/min) following administration of sheep anti-mouse GBM globulin. TAP-1−/− mice, which have extremely low MHC I expression and reduced CD8+ T cells, developed similar GN with 39 ± 3% crescents, proteinuria (12·7 ± 4·3 mg/20 h) and impaired renal function (creatinine clearance 123 ± 20 μl/min). In vivo antibody-induced CD8 depletion did not attenuate crescent formation or protect renal function in C57Bl/6 mice developing GN, although significant reduction in proteinuria (5·3 ± 1·2 mg/20 h, P = 0·012) and glomerular recruitment of CD4+ T cells and macrophages were observed compared with control treated mice with GN. These data demonstrate that MHC I is not required for development of crescentic GN in mice. The MHC I-independent contribution of CD8+ T cells to proteinuria and inflammatory cell recruitment suggests that they may serve a ‘helper’ rather than cytolytic role in this disease.
- 24 December 2000
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 122 (3) , 453-458
MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice
SUMMARY: MHC II and CD4+ T cells are required for anti-glomerular basement membrane (GBM) globulin-initiated crescentic glomerulonephritis (GN) in mice, but the role of MHC I and CD8+ T cells is unclear. The cytolytic function of CD8+ T cells requires recognition of peptide antigens presented on MHC I. CD8+ T cells can also perform helper functions via cytokine production. The contribution of MHC I to crescentic GN was investigated using TAP-1 gene knock out (TAP-1−/−) mice, which have deficient MHC I antigen presentation. Heterozygous TAP-1 mice have normal MHC I expression and developed GN with crescents in 42 ± 4% of glomeruli (normal 0%), proteinuria (9·1 ± 1·6 mg/20 h, normal 1·5 ± 0·3 mg/20 h) and impaired renal function (creatinine clearance 110 ± 8 μl/min, normal 193 ± 10 μl/min) following administration of sheep anti-mouse GBM globulin. TAP-1−/− mice, which have extremely low MHC I expression and reduced CD8+ T cells, developed similar GN with 39 ± 3% crescents, proteinuria (12·7 ± 4·3 mg/20 h) and impaired renal function (creatinine clearance 123 ± 20 μl/min). In vivo antibody-induced CD8 depletion did not attenuate crescent formation or protect renal function in C57Bl/6 mice developing GN, although significant reduction in proteinuria (5·3 ± 1·2 mg/20 h, P = 0·012) and glomerular recruitment of CD4+ T cells and macrophages were observed compared with control treated mice with GN. These data demonstrate that MHC I is not required for development of crescentic GN in mice. The MHC I-independent contribution of CD8+ T cells to proteinuria and inflammatory cell recruitment suggests that they may serve a ‘helper’ rather than cytolytic role in this disease.